GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Earnings per Share (Diluted)

Sphere Medical Holding (LSE:SPHR) Earnings per Share (Diluted) : £-0.03 (TTM As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Earnings per Share (Diluted)?

Sphere Medical Holding's Earnings per Share (Diluted) for the six months ended in Dec. 2016 was £-0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.03.

Sphere Medical Holding's EPS (Basic) for the six months ended in Dec. 2016 was £-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.03.

Sphere Medical Holding's EPS without NRI for the six months ended in Dec. 2016 was £-0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.03.

During the past 3 years, the average EPS without NRIGrowth Rate was -31.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -36.00% per year.

During the past 9 years, Sphere Medical Holding's highest 3-Year average EPS without NRI Growth Rate was 8.70% per year. The lowest was -37.50% per year. And the median was -32.45% per year.


Sphere Medical Holding Earnings per Share (Diluted) Historical Data

The historical data trend for Sphere Medical Holding's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Earnings per Share (Diluted) Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only -0.20 -0.10 -0.09 -0.05 -0.03

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.01 -0.01 -0.02

Competitive Comparison of Sphere Medical Holding's Earnings per Share (Diluted)

For the Medical Devices subindustry, Sphere Medical Holding's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's PE Ratio distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's PE Ratio falls into.



Sphere Medical Holding Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Sphere Medical Holding's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2016 is calculated as

Diluted Earnings Per Share (A: Dec. 2016 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.513-0)/141.758
=-0.03

Sphere Medical Holding's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2016 is calculated as

Diluted Earnings Per Share (Q: Dec. 2016 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-2.471-0)/141.758
=-0.02

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Sphere Medical Holding  (LSE:SPHR) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sphere Medical Holding Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.